Literature DB >> 11809444

Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial).

Larry J Diaz-Sandoval1, Bernard D Kosowsky, Douglas W Losordo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11809444     DOI： 10.1016/s0002-9149(01)02243-3

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  36 in total

1.  Non-contrast-enhanced magnetic resonance angiography is equal to contrast-enhanced multislice computed tomography for correct aortic sizing before transcatheter aortic valve implantation.

Authors:  Peter Bernhardt; Christoph Rodewald; Julia Seeger; Birgid Gonska; Dominik Buckert; Michael Radermacher; Vinzenz Hombach; Wolfgang Rottbauer; Jochen Wöhrle
Journal:  Clin Res Cardiol       Date:  2015-09-22       Impact factor: 5.460

Review 2.  Contrast nephropathy.

Authors:  Shereif H Rezkalla
Journal:  Clin Med Res       Date:  2003-10

Review 3.  How to protect from contrast media-induced nephropathy?

Authors:  B Scheller
Journal:  Clin Res Cardiol       Date:  2007-03       Impact factor: 5.460

4.  Trimetazidine in the prevention of contrast-induced nephropathy after coronary procedures.

Authors:  Alper O Onbasili; Yavuz Yeniceriglu; Pinar Agaoglu; Aslihan Karul; Tarkan Tekten; Harun Akar; Guzel Discigil
Journal:  Heart       Date:  2006-10-25       Impact factor: 5.994

5.  Incidence and risk factors for radiocontrast-induced nephropathy in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization.

Authors:  Hyun Seop Cho; Jong Woo Seo; Yeojin Kang; Eun Jin Bae; Hyun-Jung Kim; Se-Ho Chang; Dong Jun Park
Journal:  Clin Exp Nephrol       Date:  2011-06-23       Impact factor: 2.801

6.  Low rate of contrast-induced Nephropathy after CT perfusion and CT angiography in acute stroke patients.

Authors:  R Dittrich; S Akdeniz; S P Kloska; T Fischer; M A Ritter; P Seidensticker; W Heindel; E B Ringelstein; D G Nabavi
Journal:  J Neurol       Date:  2007-11-09       Impact factor: 4.849

7.  N-acetylcysteine does not prevent contrast-induced nephropathy after cardiac catheterization in patients with diabetes mellitus and chronic kidney disease: a randomized clinical trial.

Authors:  Manouchehr Amini; Mojtaba Salarifar; Alireza Amirbaigloo; Farzad Masoudkabir; Fatemeh Esfahani
Journal:  Trials       Date:  2009-06-29       Impact factor: 2.279

Review 8.  Prevention and treatment of contrast-associated nephropathy in interventional cardiology.

Authors:  Adriano Caixeta; Eugenia Nikolsky; Roxana Mehran
Journal:  Curr Cardiol Rep       Date:  2009-09       Impact factor: 2.931

Review 9.  Management of acute renal failure in the elderly patient: a clinician's guide.

Authors:  Ching M Cheung; Arvind Ponnusamy; John G Anderton
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 10.  Prevention of contrast-induced AKI: a review of published trials and the design of the prevention of serious adverse events following angiography (PRESERVE) trial.

Authors:  Steven D Weisbord; Martin Gallagher; James Kaufman; Alan Cass; Chirag R Parikh; Glenn M Chertow; Kendrick A Shunk; Peter A McCullough; Michael J Fine; Maria K Mor; Robert A Lew; Grant D Huang; Todd A Conner; Mary T Brophy; Joanne Lee; Susan Soliva; Paul M Palevsky
Journal:  Clin J Am Soc Nephrol       Date:  2013-05-09       Impact factor: 8.237
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.